JASPER THERAPEUTICS, INC. Current Assets
JASPER THERAPEUTICS, INC. (JSPR) had Current Assets of $11.57 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $11.57M.
- 2026-03-31: Assets, Current $20.29M.
- 2025-12-31: Assets, Current $34.65M.
- 2025-09-30: Assets, Current $54.56M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.57M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $20.29M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $34.65M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $54.56M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $42.97M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $53.17M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $75.81M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $94.81M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $108.68M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $120.31M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $88.94M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $105.22M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $118.57M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $132.51M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $41.73M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $52.41M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $63.29M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $73.80M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $87.83M 10-K · filed 2023-03-08 | |
| 2021-09-30 | $102.41M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $422.93K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $756.80K 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $20.68M 10-K · filed 2022-03-18 | $921.64K 10-K · filed 2021-03-30 |
| 2020-09-30 | $963.51K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.18M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.39M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.54M 10-K/A · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |